文献リスト

1）Friedrich-Rust M, Wunder K, Kriener S, et al. Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. Radiology. 2009; 252: 595-604

2）Sporea I, Bota S, Peck-Radosavljevic M, et al. Acoustic radiation force impulse elastography for fibrosis evaluation in patients with chronic hepatitis C: an international multicenter study. Eur J Radiol. 2012; 81: 4112-8

3）Ebinuma H, Saito H, Komuta M, et al. Evaluation of liver fibrosis by transient elastography using acoustic radiation force impulse: comparison with Fibroscan((R)). J Gastroenterol. 2011; 46: 1238-48

4）Karlas TF, Pfrepper C, Rosendahl J, et al. Acoustic radiation force impulse (ARFI) elastography in acute liver failure: necrosis mimics cirrhosis. Z Gastroenterol. 2011; 49: 443-8

5）Bota S, Sporea I, Sirli R, et al. Factors that influence the correlation of acoustic radiation force impulse (ARFI), elastography with liver fibrosis. Med Ultrason. 2011; 13: 135-40

6）Bavu E, Gennisson JL, Couade M, et al. Noninvasive in vivo liver fibrosis evaluation using supersonic shear imaging: a clinical study on 113 hepatitis C virus patients. Ultrasound Med Biol. 2011; 37: 1361-73

7）Yada N, Kudo M, Morikawa H, et al. Assessment of liver fibrosis with real-time tissue elastography in chronic viral hepatitis. Oncology. 2013; 84 (suppl 1): 13-20

8）Ochi H, Hirooka M, Koizumi Y, et al. Real-time tissue elastography for evaluation of hepatic fibrosis and portal hypertension in nonalcoholic fatty liver diseases. Hepatology. 2012; 56: 1271-8

9）Fiorini E, Cipriano V, De Molo C, et al. Real-time elastography as a noninvasive technique for quantification of fibrosis in patients with chronic viral liver disease: Preliminary findings.J Ultrasound. 2012; 15: 220-5

10）Kazemi F, Kettaneh A, NʼKontchou G, et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol. 2006; 45: 230-5

11）Vizzutti F, Arena U, Romanelli RG, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology. 2007; 45: 1290-7

12）Castera L, Pinzani M, Bosch J. Non invasive evaluation of portal hypertension using transient elastography. J Hepatol. 2012; 56: 696-703

13）Fung J, Lai CL, But D, et al. Prevalence of fibrosis and cirrhosis in chronic hepatitis B: implications for treatment and management. Am J Gastroenterol. 2008; 103: 1421-6

14）Wong GL, Wong VW, Choi PC, et al. Evaluation of alanine transaminase and hepatitis B virus DNA to predict liver cirrhosis in hepatitis B e antigen-negative chronic hepatitis B using transient elastography. Am J Gastroenterol. 2008; 103: 3071-81

15）Foucher J, Chanteloup E, Vergniol J, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut. 2006; 55: 403-8

16）Nahon P, Kettaneh A, Tengher-Barna I, et al. Assessment of liver fibrosis using transient elasto­graphy in patients with alcoholic liver disease. J Hepatol. 2008; 49: 1062-8

17）Corpechot C, El Naggar A, Poujol-Robert A, et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology. 2006; 43: 1118-24

18）Gomez-Dominguez E, Mendoza J, Garcia-Buey L, et al. Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis. Aliment Pharmacol Ther. 2008; 27: 441-7

19）de Ledinghen V, Douvin C, Kettaneh A, et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr. 2006; 41: 175-9

20）Talwalkar JA, Kurtz DM, Schoenleber SJ, et al. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2007; 5: 1214-20

21）Masuzaki R, Tateishi R, Yoshida H, et al. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. Hepatology. 2009; 49: 1954-61

22）Jung KS, Kim SU, Ahn SH, et al. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology. 2011; 53: 885-94

23）Wong GL, Chan HL, Wong CK. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B. J Hepatol. 2013; in press

24）Bota S, Piscaglia F, Marinelli S, et al.Comparison of International Guidelines for Noninvasive Diagnosis of Hepatocellular Carcinoma. Liver Cancer. 2012; 1: 190-200

25）Leoni S, Piscaglia F, Granito A, et al. Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted? Ultraschall Med. 2013; 34: 280-7

26）Jang HJ, Kim TK, Khalili K. Characterization of 1-to 2-cm liver nodules detected on HCC surveillance ultrasound according to the criteria of the American Association for the Study of Liver Disease: is quadriphasic CT necessary? AJR Am J Roentgenol. 2013; 201: 314-21

27）Kudo M, Hatanaka K, Maekawa K. Newly developed novel ultrasound technique, defect reperfusion ultrasound imaging, using sonazoid in the management of hepatocellular carcinoma.Oncology. 2010; 78 Suppl 1: 40-5

28）Minami Y, Kitai S, Kudo M. Treatment response assessment of radiofrequency ablation for hepatocellular carcinoma: usefulness of virtual CT sonography with magnetic navigation. Eur J Radiol. 2012; 81: e277-80

29）Makino Y, Imai Y, Ohama H. Ultrasonography fusion imaging system increases the chance of radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on conventional ultrasonography. Oncology. 2013; 84 Suppl 1: 44-50

30）Lee MW, Rhim H. Cha DI. Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography. AJR Am J Roentgenol. 2012; 198: 1438-44

31）Guibal A, Bertin C, Egels S, Contrast-enhanced ultrasound (CEUS) follow-up after radiofrequency ablation or cryoablation of focal liver lesions: treated-area patterns and their changes over time. Eur Radiol. 2013; 23: 1392-400

32）Takahashi M, Maruyama H, Shimada T. Linear enhancement after radio-frequency ablation for hepatocellular carcinoma: is it a sign of recurrence? Ultrasound Med Biol. 2012; 38: 1902-10

33）Dahl J, Jakovljevic M, Pinton GF, et al. Harmonic spatial coherence imaging: an ultrasonic imaging method based on backscatter coherence. IEEE Trans Ultrason Ferroelectr Freq Control. 2012; 59: 648-59

34）Chiou SY, Forsberg F, Fox TB, et al. Comparing differential tissue harmonic imaging with tissue harmonic and fundamental gray scale imaging of the liver. J Ultrasound Med. 2007; 26: 1557-63

35）Schacherer D, Schuh C, Strauch U, et al. Improvement in the routine diagnostic assessment of the liver by high-resolution sonography: an analysis of 999 cases. Scand J Gastroenterol. 2007; 42: 366-73

36）Kim SH, Lee JM, Kim KG, et al. Comparison of fundamental sonography, tissue-harmonic sonography, fundamental compound sonography, and tissue-harmonic compound sonography for focal hepatic lesions. Eur Radiol. 2006; 16: 2444-53

37）Xu H, Xie X, Lu M, et al. Contrast-enhanced sonography in the diagnosis of small hepatocellular carcinoma < or =2 cm. J Clin Ultrasound. 2008; 36: 257-66

38）Imai Y, Murakami T, Yoshida S, et al. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology. 2000; 32: 205-12

39）Tanaka M, Nakashima O, Wada Y, et al. Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver. Hepatology. 1996; 24: 807-12

40）Korenaga K, Korenaga M, Furukawa M, et al. Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images. J Gastroenterol. 2009; 44: 733-41

41）Inoue T, Kudo M, Watai R, et al. Differential diagnosis of nodular lesions in cirrhotic liver by post-vascular phase contrast-enhanced US with Levovist: comparison with superparamagnetic iron oxide magnetic resonance images. J Gastroenterol. 2005; 40: 1139-47

42）Sugimoto K, Moriyasu F, Kamiyama N, et al. Analysis of morphological vascular changes of hepatocellular carcinoma by microflow imaging using contrast-enhanced sonography. Hepatol Res. 2008; 38: 790-9

43）Sugimoto K, Moriyasu F, Kamiyama N, et al. Correlation between parametric imaging using contrast ultrasound and the histological differentiation of hepatocellular carcinoma. Hepatol Res. 2008; 38: 273-80

44）Sehgal C, Cary T, Arger P, et al. Delta-projection imaging on contrast-enhanced ultrasound to quantify tumor microvasculature and perfusion. Acad Radiol. 2009; 16: 71-8

45）Tanaka H, Iijima H, Higashiura A. New malignant grading system for hepatocellular carcinoma using the Sonazoid contrast agent for ultrasonography. J Gastroenterol. 2013; in press

46）Sato K, Tanaka S, Mitsunori Y. Contrast-enhanced intraoperative ultrasonography for vascular imaging of hepatocellular carcinoma: clinical and biological significance. Hepatology. 2013; 57: 1436-47

47）Sugimoto K, Moriyasu F, Saito K. Hepatocellular carcinoma treated with sorafenib: early detection of treatment response and major adverse events by contrast-enhanced US. Liver Int. 2013; 33: 605-15

48）Zocco MA, Garcovich M, Lupascu A. Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: The role of dynamic contrast enhanced ultrasound. J Hepatol. 2013; 59: 1014-21

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp